HLA-DRA Antikörper
Kurzübersicht für HLA-DRA Antikörper (ABIN7605128)
Target
Alle HLA-DRA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- Anti-HLA-DRA/Hla Dr Rabbit Monoclonal Antibody
-
Produktmerkmale
- Anti-HLA-DRA/Hla Dr Rabbit Monoclonal Antibody (ABIN7605128). Tested in WB, IHC, ICC/IF, Flow Cytometry applications. This antibody reacts with Human.
-
Aufreinigung
- Affinity-chromatography
-
Immunogen
- A synthesized peptide derived from human HLA-DRA
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:1000-1:5000
IHC 1:50-1:200
ICC/IF 1:50-1:200
FC 1:50 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Rekonstitution
- Restore with deionized water (or equivalent) for reconstitution volume of 1.0 mL
-
Konzentration
- Lot specific
-
Buffer
- Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol, 0.4-0.5 mg/mL BSA.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at -20°C for one year. For short term storage and frequent use, store at 4°C for up to one month. Avoid repeated freeze-thaw cycles.
-
-
- HLA-DRA (HLA Class II DR alpha (HLA-DRA))
-
Andere Bezeichnung
- HLA-DRA
-
Hintergrund
-
Synonyms: HLA class II histocompatibility antigen, DR alpha chain,MHC class II antigen DRA,HLA-DRA,HLA-DRA1,
Tissue Specificity: Ubiquitous. Expression is strongest in fetal and adult brain, spinal cord, and cerebellum, followed by thymus, bone marrow, testis, and fetal liver. Expression is intermediate in colon, ovary, placenta, uterus, and trachea, and is readily detected at substantially lower levels in all other tissues examined. Lowest expression is found in adult liver. Present in much greater abundance in cells from patients with acute leukemia of different subtypes than in normal peripheral blood lymphocytes, non-leukemic proliferating lymphoid cells, bone marrow cells, or cells from patients with chronic lymphoid or myeloid leukemia. .
-
Molekulargewicht
- 17 kDa
-
UniProt
- P01903
-
Pathways
- T-Zell Rezeptor Signalweg, CXCR4-mediated Signaling Events, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Target
-